News
FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...
The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...
21h
Medical Device Network on MSNAre regulators keeping pace with AI adoption in clinical trials?While both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released guidance on the ...
The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...
Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...
The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...
Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...
Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.
AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...
The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results